NCT04451291View on ClinicalTrials.gov

Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

November 7, 2023

Study Completion Date

November 7, 2023

Conditions
COVID-19Acute Respiratory Distress Syndrome
Interventions
BIOLOGICAL

Decidual Stromal Cells (DSC)

DSCs are involved in the immune system during pregnancy. The DSCs used in this study will come from laboratory grown allogeneic human decidual stromal cells obtained from donated placentas.

Trial Locations (3)

L6R 3J7

Brampton Civic Hospital, Brampton

M9V 1R8

Etobicoke General Hospital, Etobicoke

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

lead

University Health Network, Toronto

OTHER

NCT04451291 - Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure | Biotech Hunter | Biotech Hunter